Nexlizet recall: Failed Dissolution
Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC…
Why was Nexlizet recalled?
Failed dissolution specifications: below specification results at stability 12-month
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025
- Product
- Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC…
- Recalling firm
- Esperion
- Quantity
- 45,240 bottles
- Distribution
- Nationwide USA
- Recall date
- September 13, 2023
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)